Addus HomeCare (NASDAQ:ADUS) Director Esteban Lopez Sells 150 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 150 shares of the company’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $115.18, for a total value of $17,277.00. Following the transaction, the director directly owned 3,700 shares in the company, valued at $426,166. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Esteban Lopez also recently made the following trade(s):

• On Friday, December 5th, Esteban Lopez sold 166 shares of Addus HomeCare stock. The stock was sold at an average price of $112.78, for a total value of $18,721.48.

Addus HomeCare Trading Down 1.4%

Addus HomeCare stock traded down $1.65 during trading hours on Tuesday, reaching $113.49. 138,318 shares of the company’s stock traded hands, compared to its average volume of 182,430. The firm has a market capitalization of $2.10 billion, a price-to-earnings ratio of 24.30, a PEG ratio of 1.54 and a beta of 0.94. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The firm’s 50 day moving average is $115.81 and its 200-day moving average is $113.83.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.53 by $0.03. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. The company had revenue of $362.30 million during the quarter, compared to analysts’ expectations of $354.48 million. During the same quarter in the previous year, the company earned $1.30 EPS. Addus HomeCare’s revenue was up 25.0% on a year-over-year basis. On average, analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Analyst Upgrades and Downgrades

ADUS has been the subject of several recent research reports. Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. TD Cowen lifted their price objective on Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, October 8th. BMO Capital Markets started coverage on Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price on the stock. Finally, Stephens restated an “overweight” rating and set a $140.00 target price on shares of Addus HomeCare in a research report on Wednesday, September 3rd. Eight equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $137.11.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Larson Financial Group LLC increased its holdings in shares of Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after acquiring an additional 136 shares in the last quarter. AlphaQuest LLC bought a new position in shares of Addus HomeCare during the 3rd quarter valued at about $37,000. Wexford Capital LP acquired a new position in shares of Addus HomeCare in the 3rd quarter valued at approximately $41,000. State of Wyoming acquired a new position in shares of Addus HomeCare in the 2nd quarter valued at approximately $47,000. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in Addus HomeCare during the 1st quarter worth approximately $41,000. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.